收藏切换
Recent advances of conditionally active antibodies
收藏切换
PDF
Yang-yang CHEN1, 2, Ai-ying XIONG2, Seng ZHU2, Ge SONG2, Hong TIAN1, *
Acta Pharmaceutica Sinica | 2024, 59(9) : 2429 - 2442
Less
收藏切换
Acta Pharmaceutica Sinica | 2024, 59(9): 2429-2442
Recent advances of conditionally active antibodies
Full
Yang-yang CHEN1, 2, Ai-ying XIONG2, Seng ZHU2, Ge SONG2, Hong TIAN1, *
Affiliations
  • 1. School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China
  • 2. Shanghai Innovation Center, Shanghai Henlius Biotech, Inc., Shanghai 200233, China
Published: 2024-09-12 doi: 10.16438/j.0513-4870.2024-0071
Outline
收藏切换

The high selectivity and affinity of antibody binding make antibodies widely used in therapeutics, diagnostics, and basic sciences. However, the toxicity of some antibodies has limited their utility. In the past decade, by increasing tissue specificity, conditionally active antibodies have further improved the safety and efficacy of antibodies, widened or even created a therapeutic window. Conditionally active antibodies are antibodies activatable under particular stimuli but have little or no antigen-binding activity in circulation and normal tissues. Conditionally active antibodies are designed to respond to endogenous or exogenous stimuli, such as light, temperature, enzymatic activity, pH, adenosine triphosphate (ATP), ions, effector molecules, and antigen combinations. Currently, two pH-activated antibodies have been approved for clinical use, and multiple conditionally active antibodies have entered clinical trials. This article describes the current status of the field of conditionally active antibodies, focusing on the three major types of conditionally active antibodies activated by pH, ATP and protease, including their design principles, implementation methods, relevant examples and the latest research progress. In addition, this review summarizes tumor-associated proteases and discusses the role of several key proteases in the development and progression of cancer, which can provide reference for the research and development of conditionally active antibodies. Many opportunities remain untapped in this field, waiting for more efficient and generally applicable activation strategies to be developed at the interface between chemistry and biotechnology.

conditional activation  /  antibody  /  pH  /  adenosine triphosphate  /  tumor-associated protease
Yang-yang CHEN, Ai-ying XIONG, Seng ZHU, Ge SONG, Hong TIAN. Recent advances of conditionally active antibodies[J]. Acta Pharmaceutica Sinica, 2024 , 59 (9) : 2429 -2442 . DOI: 10.16438/j.0513-4870.2024-0071
Year 2024 volume 59 Issue 9
PDF
244
118
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2024-0071
  • Receive Date:2024-01-23
  • Online Date:2025-11-24
  • Published:2024-09-12
Article Data
Affiliations
History
  • Received:2024-01-23
  • Revised:2024-04-22
Affiliations
    1. School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China
    2. Shanghai Innovation Center, Shanghai Henlius Biotech, Inc., Shanghai 200233, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2024-0071
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT